论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Mifflin MD, Betts BS, Frederick PA, Feuerman JM, Fenzl CR, Moshirfar M, Zaugg B
Received 29 March 2017
Accepted for publication 1 May 2017
Published 12 June 2017 Volume 2017:11 Pages 1113—1118
DOI https://doi.org/10.2147/OPTH.S138272
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Purpose: To
compare the outcome of photorefractive keratectomy (PRK) and complications in
patients treated with either loteprednol etabonate 0.5% gel or prednisolone
acetate 1% suspension and fluorometholone (fml) 0.1% suspension.
Setting: John A Moran Eye Center, University of Utah, Salt Lake
City, UT, USA.
Design: Prospective, randomized, partially masked trial.
Methods: PRK was performed on 261 eyes of 132 participants.
Patients were randomized to a postoperative corticosteroid regimen of either
loteprednol etabonate 0.5% gel (loteprednol) or prednisolone 1% acetate
suspension followed by fluorometholone 0.1% suspension (prednisolone/fml).
Primary outcome measures included incidence and grade of postoperative corneal
haze and incidence of increased intraocular pressure of 10 mmHg above baseline,
or any intraocular pressure over 21 mmHg. Secondary outcome measures included
uncorrected distance visual acuity, best corrected distance visual acuity, and
manifest refraction spherical equivalent.
Results: The incidence of haze in the first 3 months was 2.6%
(3/114 eyes) in the loteprednol group and 4.8% (7/147 eyes) in the
prednisolone/fml group and was not statistically significant between groups (P =0.37). The incidence of elevated
intraocular pressure was 1.8% (2/114 eyes) in the loteprednol group and 4.1%
(6/147 eyes) in the prednisolone/fml group, and was not statistically
significant between the groups (P =0.12). The mean
3-month postoperative logMAR uncorrected visual acuity was −0.078±0.10 and
−0.075±0.09 in the loteprednol and prednisolone/fml groups, respectively (P =0.83).
Conclusion: Postoperative corneal haze and elevated intraocular
pressure were uncommon in both treatment arms. There was no statistically
significant difference between each postoperative regimen. Refractive results
were similar and excellent in both treatment arms. A tapered prophylactic
regimen of loteprednol 0.5% gel is equally effective to prednisolone 1%/fml
0.1% after PRK.
Keywords: PRK,
corticosteroid, fluorometholone, loteprednol, lotemax, wavefront optimized
